Cagrilintide in the Broader Peptide Landscape The metabolic peptide field has expanded dramatically, with various compounds targeting different aspects of metabolism: GLP-1 agonists (semaglutide, liraglutide) Single incretin pathway Dual agonists (tirzepatide) GIP + GLP-1 pathways Amylin analogues (cagrilintide) Amylin pathway Triple agonists (retatrutide) GIP + GLP-1 + Glucagon Metabolic modulators (5-Amino-1MQ) NNMT inhibition Each class offers unique mechanisms and potential applications in metabolic research
But what about injections
Journal of Clinical Oncology , 31 (14), 17191725
However, based on the research to date, researchers will want to consider the following guidelines when when administering these peptides: Subcutaneous and intramuscular injections are considered more effective due to enhanced bioavailability , but using BPC-157 + TB-500 nasal spray could have certain advantages depending on the therapeutic objective and study design
Mild and transient side effects
The article also flags patients with limited dexterity, vision impairment, or no access to sterile supplies, who may be better served by pre-filled injection pens or provider-administered doses